SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-057472
Filing Date
2019-10-30
Accepted
2019-10-30 06:17:54
Documents
72
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20190930x10q939d4f.htm   iXBRL 10-Q 2506431
2 EX-31.1 ex-31d1.htm EX-31.1 15141
3 EX-31.2 ex-31d2.htm EX-31.2 15291
4 EX-32.1 ex-32d1.htm EX-32.1 7864
5 EX-32.2 ex-32d2.htm EX-32.2 7865
  Complete submission text file 0001104659-19-057472.txt   9641460

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA uthr-20190930.xsd EX-101.SCH 56877
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE uthr-20190930_cal.xml EX-101.CAL 64641
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE uthr-20190930_def.xml EX-101.DEF 271172
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20190930_lab.xml EX-101.LAB 577292
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20190930_pre.xml EX-101.PRE 422965
17 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20190930x10q939d4f_htm.xml XML 2013774
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 191177534
SIC: 2834 Pharmaceutical Preparations